vs

Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $46.9M, roughly 1.8× Caledonia Mining Corp Plc). Caledonia Mining Corp Plc runs the higher net margin — 7.0% vs -38.1%, a 45.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 13.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.1%).

Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CMCL vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.8× larger
PRCT
$83.1M
$46.9M
CMCL
Growing faster (revenue YoY)
PRCT
PRCT
+6.4% gap
PRCT
20.2%
13.8%
CMCL
Higher net margin
CMCL
CMCL
45.1% more per $
CMCL
7.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
17.1%
CMCL

Income Statement — Q3 FY2024 vs Q1 FY2026

Metric
CMCL
CMCL
PRCT
PRCT
Revenue
$46.9M
$83.1M
Net Profit
$3.3M
$-31.6M
Gross Margin
41.2%
64.9%
Operating Margin
18.6%
-4.1%
Net Margin
7.0%
-38.1%
Revenue YoY
13.8%
20.2%
Net Profit YoY
-33.3%
-27.9%
EPS (diluted)
$0.13
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCL
CMCL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$83.3M
Q2 25
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$46.9M
$58.4M
Q2 24
$50.1M
$53.4M
Net Profit
CMCL
CMCL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-21.4M
Q2 25
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$3.3M
$-21.0M
Q2 24
$10.2M
$-25.6M
Gross Margin
CMCL
CMCL
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
41.2%
63.2%
Q2 24
45.8%
59.0%
Operating Margin
CMCL
CMCL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
Q2 25
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
18.6%
-38.4%
Q2 24
32.2%
-50.3%
Net Margin
CMCL
CMCL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-25.7%
Q2 25
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
7.0%
-35.9%
Q2 24
20.3%
-48.0%
EPS (diluted)
CMCL
CMCL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$0.13
$-0.40
Q2 24
$0.42
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCL
CMCL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$7.2M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$231.0M
$347.7M
Total Assets
$339.7M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCL
CMCL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$7.2M
$196.8M
Q2 24
$15.4M
$214.1M
Total Debt
CMCL
CMCL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CMCL
CMCL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$380.3M
Q2 25
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$231.0M
$241.2M
Q2 24
$231.1M
$251.8M
Total Assets
CMCL
CMCL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$511.5M
Q2 25
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$339.7M
$374.1M
Q2 24
$338.5M
$374.4M
Debt / Equity
CMCL
CMCL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCL
CMCL
PRCT
PRCT
Operating Cash FlowLast quarter
$4.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCL
CMCL
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$-6.6M
Q2 25
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$4.6M
$-18.8M
Q2 24
$19.1M
$-15.7M
Free Cash Flow
CMCL
CMCL
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
CMCL
CMCL
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
CMCL
CMCL
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
CMCL
CMCL
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.40×
Q2 24
1.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMCL
CMCL

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons